Publications by authors named "Matteo Andreini"

Claim this Profile
N
Noncanonical-NF-κB activation and DDX3 inhibition reduces the HIV-1 reservoir by elimination of latently infected cells .
Jade Jansen, Stefanie Kroeze, Shirley Man, Matteo Andreini, Jan-Willem Bakker

Microbiol Spectr· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The FHP01 DDX3X Helicase Inhibitor Exerts Potent Anti-Tumor Activity In Vivo in Breast Cancer Pre-Clinical Models.
Lisa Gherardini, Giovanni Inzalaco, Francesco Imperatore, Romina D'Aurizio, Lorenzo Franci, Matteo Andreini

Cancers (Basel)· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of linear and cyclic peptide inhibitors of KEAP1-NRF2 protein-protein interaction.
Stefania Colarusso, Daniele De Simone, Tommaso Frattarelli, Matteo Andreini, Mauro Cerretani

Bioorg Med Chem· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined Peptide and Small-Molecule Approach toward Nonacidic THIQ Inhibitors of the KEAP1/NRF2 Interaction.
Jesus M Ontoria, Ilaria Biancofiore, Paola Fezzardi, Federica Ferrigno, Esther Torrente, Matteo Andreini

ACS Med Chem Lett· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and binding mode of a novel Leishmania Trypanothione reductase inhibitor from high throughput screening.
Lorenzo Turcano, Esther Torrente, Antonino Missineo, Matteo Andreini, Marina Gramiccia

PLoS Negl Trop Dis· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peptidomimetic nitrile inhibitors of malarial protease falcipain-2 with high selectivity against human cathepsins.
Emanuela Nizi, Alessio Sferrazza, Danilo Fabbrini, Valentina Nardi, Matteo Andreini

Bioorg Med Chem Lett· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery by organism based high-throughput screening of new multi-stage compounds affecting Schistosoma mansoni viability, egg formation and production.
Alessandra Guidi, Cristiana Lalli, Roberto Gimmelli, Emanuela Nizi, Matteo Andreini

PLoS Negl Trop Dis· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification by High-Throughput Screening of Pseudomonas Acyl-Coenzyme A Synthetase Inhibitors.
Lorenzo Turcano, Daniela Visaggio, Emanuela Frangipani, Antonino Missineo, Matteo Andreini

SLAS Discov· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The soluble Y115E-Y117E variant of human glutaminyl cyclase is a valid target for X-ray and NMR screening of inhibitors against Alzheimer disease.
Flavio DiPisa, Cecilia Pozzi, Manuela Benvenuti, Matteo Andreini, Guido Marconi

Acta Crystallogr F Struct Biol Commun· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-activity relationship and properties optimization of a series of quinazoline-2,4-diones as inhibitors of the canonical Wnt pathway.
Arianna Nencini, Carmela Pratelli, Joanna M Quinn, Massimiliano Salerno, Patrizia Tunici, Matteo Andreini

Eur J Med Chem· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
siRNA screen identifies QPCT as a druggable target for Huntington's disease.
Maria Jimenez-Sanchez, Wun Lam, Michael Hannus, Birte Sönnichsen, Sara Imarisio, Matteo Andreini

Nat Chem Biol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BACE1 inhibitors: a head group scan on a series of amides.
Thomas J Woltering, Wolfgang Wostl, Hans Hilpert, Mark Rogers-Evans, Emmanuel Pinard, Matteo Andreini

Bioorg Med Chem Lett· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacophore based receptor modeling: the case of adenosine A3 receptor antagonists. An approach to the optimization of protein models.
Andrea Tafi, Cesare Bernardini, Maurizio Botta, Federico Corelli, Matteo Andreini

J Med Chem· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis